133 related articles for article (PubMed ID: 15276302)
21. Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands.
Farhad M; Yu JQ; Beale P; Fisher K; Huq F
ChemMedChem; 2009 Nov; 4(11):1841-9. PubMed ID: 19746359
[TBL] [Abstract][Full Text] [Related]
22. Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.
Rakić GM; Grgurić-Sipka S; Kaluderović GN; Gómez-Ruiz S; Bjelogrlić SK; Radulović SS; Tesić ZLj
Eur J Med Chem; 2009 May; 44(5):1921-5. PubMed ID: 19070943
[TBL] [Abstract][Full Text] [Related]
23. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
[TBL] [Abstract][Full Text] [Related]
25. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization and cytotoxicity of diam(m)-ineplatinum(II) complexes containing beta-phenylisosuccinate ligand.
Ye QS; Lou LG; Liu ZY; Liu WP; Hou SQ; Chen XZ; Yu Y
Arch Pharm (Weinheim); 2007 Nov; 340(11):599-602. PubMed ID: 17924364
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and cytotoxicity of three trans-palladium complexes containing planaramine ligands in human ovarian tumor models.
Mazumder ME; Beale P; Chan C; Yu JQ; Huq F
ChemMedChem; 2012 Oct; 7(10):1840-6. PubMed ID: 22899663
[TBL] [Abstract][Full Text] [Related]
29. Influence of the position of substituents in the cytotoxic activity of trans platinum complexes with hydroxymethyl pyridines.
Martínez A; Lorenzo J; Prieto MJ; Font-Bardia M; Solans X; Avilés FX; Moreno V
Bioorg Med Chem; 2007 Jan; 15(2):969-79. PubMed ID: 17088064
[TBL] [Abstract][Full Text] [Related]
30. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
33. Zinc(II) complexes derived from pyridine-2-carbaldehyde thiosemicarbazone and (1E)-1-pyridin-2-ylethan-1-one thiosemicarbazone. Synthesis, crystal structures and antiproliferative activity of zinc(II) complexes.
Kovala-Demertzi D; Yadav PN; Wiecek J; Skoulika S; Varadinova T; Demertzis MA
J Inorg Biochem; 2006 Sep; 100(9):1558-67. PubMed ID: 16828164
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro antitumor activity of platinum acetonimine complexes.
Boccarelli A; Intini FP; Sasanelli R; Sivo MF; Coluccia M; Natile G
J Med Chem; 2006 Jan; 49(2):829-37. PubMed ID: 16420068
[TBL] [Abstract][Full Text] [Related]
35. [Imidazole derivatives. VI. Synthesis and pharmacologic activity of nitrogen-containing derivatives of imidazo-(1,2-a)-pyridine].
Almirante L; Mugnaini A; De Toma N; Murmann W
Boll Chim Farm; 1971 Jun; 110(6):322-9. PubMed ID: 5110580
[No Abstract] [Full Text] [Related]
36. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
37. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
38. Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: synthesis, characterization and antitumour activity.
Szucová L; Trávnícek Z; Zatloukal M; Popa I
Bioorg Med Chem; 2006 Jan; 14(2):479-91. PubMed ID: 16198575
[TBL] [Abstract][Full Text] [Related]
39. Synthetic route to dinuclear platinum(II) complexes [{trans-PtCl(NH3)2}2(mu-L)]2+ (L = aliphatic or heterocyclic diamine) as potential antitumor agents, exploiting the mutual activation of hydroxido ligands and ammonium groups.
Chopard C; Lenoir C; Rizzato S; Vidal M; Arpalahti J; Gabison L; Albinati A; Garbay C; Kozelka J
Inorg Chem; 2008 Oct; 47(20):9701-5. PubMed ID: 18817377
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of disubstituted imidazo[4,5-b]pyridin-2-ones.
Kuethe JT; Wong A; Davies IW
J Org Chem; 2004 Oct; 69(22):7752-4. PubMed ID: 15498009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
